Utah Medical Products, Inc.
UTMD
$56.25
$0.7651.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.50% | 6.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.50% | 6.03% | |||
| Cost of Revenue | 4.46% | 8.79% | |||
| Gross Profit | 1.03% | 4.04% | |||
| SG&A Expenses | 3.50% | -0.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.75% | 5.98% | |||
| Operating Income | 0.26% | 6.12% | |||
| Income Before Tax | -0.57% | 6.75% | |||
| Income Tax Expenses | -3.55% | 14.75% | |||
| Earnings from Continuing Operations | 0.23% | 4.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.23% | 4.79% | |||
| EBIT | 0.26% | 6.12% | |||
| EBITDA | 1.05% | 4.82% | |||
| EPS Basic | 2.21% | 7.25% | |||
| Normalized Basic EPS | 0.60% | 8.08% | |||
| EPS Diluted | 2.21% | 7.35% | |||
| Normalized Diluted EPS | 0.61% | 8.07% | |||
| Average Basic Shares Outstanding | -1.93% | -2.30% | |||
| Average Diluted Shares Outstanding | -1.94% | -2.30% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.02% | -0.07% | |||